Company performance
Add to research
Current Price
as of Apr 21, 2025$17.92
P/E Ratio
N/A
Market Cap
$553.11M
Description
Add to research
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Metrics
Add to research
Overview
- HQEl Monte, CA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerFLGT
- Price$17.92+0.34%
Trading Information
- Market cap$553.11M
- Float64.40%
- Average Daily Volume (1m)405,186
- Average Daily Volume (3m)455,064
- EPS-$1.41
Company
- Revenue$283.47M
- Rev growth (1yr)-1.99%
- Net income-$42.71M
- Gross margin35.01%
- EBITDA margin-17.28%
- EBITDA-$48.99M
- EV$305.49M
- EV/Revenue1.08
- P/EN/A
- P/S1.91
- P/B0.49
- Debt/Equity0.81
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account